BrainInsight

BrainInsight is an automated software tool designed to provide quantitative analysis of brain structures from AI-reconstructed low-field MR images using a machine learning-driven pipeline. It aims to deliver accurate volumetric measurements, segmentation of the brain and ventricles, and midline shift calculations to support clinical assessment in adult patients.

BrainInsight is an automated medical software designed for post-processing Magnetic Resonance (MR) images of adult brains (18 years or older). Its purpose is to perform automatic labeling, spatial measurement, and volumetric quantification of brain structures using low-field MR images, specifically T1 and T2 sequences acquired from the Hyperfine Swoop FSE MRI system. The software operates via a proprietary internal pipeline leveraging machine learning tools, and processes inputs in a serverless cloud environment. The outputs include annotated and segmented images, color overlays, and reports in standard DICOM format, intended for display on third-party workstations and Picture Archive and Communications Systems (PACS). The system provides functionalities such as image alignment, whole brain segmentation, ventricle segmentation, and midline shift measurements, notably processing AI-reconstructed low-field MR images. Performance evaluations demonstrated its accuracy, with mean absolute errors for midline shift reported as 1.03 mm for T1 and 0.97 mm for T2 images. Segmentation accuracy, measured by Dice coefficients against expert annotations (with ground truth established by Simultaneous Truth and Performance Level Estimation - STAPLE), was high: for T1 images, Dice scores were approximately 82-84% for lateral ventricles and 95% for whole brain; for T2 images, scores were approximately 79-81% for lateral ventricles and 96% for whole brain. These results were achieved on a diverse test dataset including various pathologies such as stroke, hydrocephalus, and tumors.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the performance of BrainInsight on AI-reconstructed low-field MR images compare to its performance on conventional low-field MR images, particularly in terms of Dice coefficients and midline shift accuracy for different pathologies?; What specific machine learning architectures are employed in the BrainInsight pipeline, and how were they optimized for low-field, AI-reconstructed MR data?; Could the BrainInsight software be adapted or validated for use with low-field MRI data from scanners other than the Hyperfine Swoop system?; What is the impact of the ~7 minute processing time on clinical workflow, and are there ongoing efforts to reduce this turnaround time further?; How does the system's performance vary across the different pathologies listed (e.g., stroke vs. tumor vs. hydrocephalus), and are there specific anatomical regions or conditions where its accuracy is notably higher or lower?